Announcements Trials
Browse Landscape

Phase

Phase 2 131Phase 1 42Phase 3 27Phase 1/2 27Phase NA 8Phase 2/3 6Phase 4 4Phase EARLY_PHASE1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 1

Conditions

Colorectal Neoplasms 2Physician Education 1Gastrointestinal Stromal Tumors 1Colorectal Cancer Metastatic 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × regorafenib × Clear all
NCT04874207 2025-08-08

RePERSO

Rennes University Hospital

Phase 4 Completed
110 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03564938 2024-12-03

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Bayer

Phase 4 Completed
100 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02800330 2018-08-02

REGORA

Erasmus Medical Center

Phase 4 Completed
31 enrolled
GastrointestinalSarcoma

Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT02287025 2017-10-19

SMART

Bayer

Phase 4 Terminated
23 enrolled 6 charts

Physician Education

Data powered by HemOnc (CC BY 4.0) Colophon âš¡